Pfizer Stock News

Pfizer Inc has signed a $5.29 billion deal with the US government to deliver 10 million courses of its COVID-19 oral antiviral drug starting this year, the drugmaker said on Thursday.The oral drug

The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators approve it

(RTTNews) - Pfizer Inc. (PFE) has made a $15 million equity investment in Cardiff Oncology Inc. (CRDF), as part of the Pfizer Breakthrough Growth Initiative, Cardiff said in a statement on Thursday. Pfizer Breakthrough Growth Initiativ is a program focused on funding innovative science to meet patient needs. In Thursday pre-market trade, CRDF

Reuters Ratio''d Into Oblivion After Fact Check Fail Defending Bill Gates After Bill Gates told a UK think tank earlier this month that the Covid-19 vaccine ''helps you with your health, but only slightly reduces transmission ," a flood of people pointed out that the billionaire vaccine proponent had essentially said the quiet part out loud - admitting that the Pfizer and Moderna mRNA vaccines ''don''t work well'' and was ''an explicit acknowledgement that the mRNA and rAdV vaccines for COVID are not working well.'' " We didnt have vaccines that block transmission. We got vaccines that help you with your health, but they only slightly reduce the transmission. So, we need a new way of doing the vaccines ," is the exact quote. Bill Gates just admitted that the Pfizer and Moderna mRNA vaccines dont work well. pic.twitter.com/6GQ3DQk8aN Ezra Levant (@ezralevant) November 9, 2021 For those who have not seen it, this is an explicit acknowledgment that the mRNA and rAdV vaccines for COVID are not working well.

The post Viatris Stock Fell in Its First Year. The CEO Sees a Unique Drug Business. appeared on BitcoinEthereumNews.com . Text size Viatris CEO Michael Goettler. Courtesy Viatris Investors have yet to warm to Viatris, created a year ago this week by the merger between a Pfizer spinoff and the generic drugmaker Mylan,

Voxzogo could reach blockbuster status with sales of $1 billion Related Stocks: BMRN , ASND , BBIO , PFE ,

The FDA and CDC could expand eligibility of the Pfizer booster shot as early as this week. The drugmaker is also seeking emergency use authorization for its COVID-19 antiviral pill, Paxlovid. CBS News'' Naomi Ruchim reports, and then Dr. William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, joins CBSN''s Tanya Rivero to discuss the latest progress in the fight against the coronavirus pandemic.

Disney''s announcement follows the US''s decision to greenlight a lower dose of the Pfizer vaccine for children who are at least five years old.

WHETHER or not you are offered the Pfizer/BioNTech or Moderna Covid vaccine is down to the supplies available on the day at the local pharmacy or vaccine centre that you attend. Read more here Daily Express :: Health Feed Covid booster vaccine: More side effects likely for third jab here is why

Bloomberg Markets and Finance published this video item, Read more

Pfizer Inc. said on Wednesday Chief Financial Officer Frank DAmelio, 63, would retire after nearly 15 years at the company. The drugmaker has started an external search for the successor of DAmelio, who also served as executive vice president of global supply. During his tenure, Pfizer slimmed down its business through sales to focus on []

The 18 infants who were mistakenly vaccinated with Pfizer Covid-19 in Hanoi are now in stable health according to local doctors. Wednesday, 17 November 2021 4:38 PM

Israeli researchers found people of all ages vaccinated in January and February had a 51 per cent higher chance of being infected in July than those jabbed in March and April.